High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$17.2M
$17,212,370
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-09 | $111,045 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-09 | $319,059 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-04 | $486,370x3 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-03-04 | $2,001,371Largex3 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-03-02 | $22,248 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
10b5-1 SellΔOwn -13.1%
|
2026-02-04 | $510,874x8 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
COO
Sell to Cover
|
2026-02-02 | $339,682x4 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2026-01-29 | $29,794x2 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2026-01-29 | $155,375 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-16 | $554,616x11 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-12-16 | $1,562,185Largex11 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -19.0%
|
2025-12-09 | $201,648 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -36.5%
|
2025-12-09 | $579,620 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-12-01 | $61,276 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
Director
Discretionary Sell
|
2025-11-24 | $6,093,967Whalex15 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to Cover
|
2025-10-29 | $52,978 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to Cover
|
2025-10-29 | $294,654x2 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
10b5-1 Sell
|
2025-09-30 | $716,261x7 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CEO
10b5-1 Sell
|
2025-09-30 | $1,390,911Largex8 | S | Form 4 |
| WGS |
GeneDx Holdings Corp.
|
CFO
Sell to CoverΔOwn -29.9%
|
2025-09-16 | $452,850 | S | Form 4 |
|
WGS
S
GeneDx Holdings Corp.
Stueland Katherine
• CEO
Sell to CoverΔOwn -41.9%
2025-09-16
$1,275,585Large
|
||||||
| WGS |
GeneDx Holdings Corp.
|
CEO
Sell to CoverΔOwn -41.9%
|
2025-09-16 | $1,275,585Large | S | Form 4 |